APA

Nyíri K., Koppány G., Pálfy G., Vida I., Tóth S., Orgován Z., Ranđelović I., Baranyi M., Molnár E., Keserû M. G., Tóvári J., Perczel A., Vértessy B. G. & Tímár J. (20200113). [Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium]. : Magyar onkologia.

Chicago

Nyíri Kinga, Koppány Gergely, Pálfy Gyula, Vida István, Tóth Szilárd, Orgován Zoltán, Ranđelović Ivan, Baranyi Marcell, Molnár Eszter, Keserû Miklós György, Tóvári József, Perczel András, Vértessy Beáta G and Tímár József. 20200113. [Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium]. : Magyar onkologia.

Harvard

Nyíri K., Koppány G., Pálfy G., Vida I., Tóth S., Orgován Z., Ranđelović I., Baranyi M., Molnár E., Keserû M. G., Tóvári J., Perczel A., Vértessy B. G. and Tímár J. (20200113). [Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium]. : Magyar onkologia.

MLA

Nyíri Kinga, Koppány Gergely, Pálfy Gyula, Vida István, Tóth Szilárd, Orgován Zoltán, Ranđelović Ivan, Baranyi Marcell, Molnár Eszter, Keserû Miklós György, Tóvári József, Perczel András, Vértessy Beáta G and Tímár József. [Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium]. : Magyar onkologia. 20200113.